全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 101980-41-0 | 2-Bromo-4-nitro-1-isopropylbenzene;1-Bromo-2-isopropyl-5-nitrobenzene | C9H10BrNO2 |
| 101987-86-4 | Ethyl 3-chloro-2,4,5-trifluorobenzoylacetate;Ethyl 2-(3-chloro-2,4,5-trifluorobenzoyl)acetate | C11H8ClF3O3 |
| 101987-89-7 | 8-Chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid | C13H8ClF2NO3 |
| 101990-45-8 | 2-Bromo-5-(bromomethyl)pyridine;6-Bromo-3-pyridylmethyl bromide | C6H5Br2N |
| 101990-68-5 | 6-Phenoxy-3-Pyridinemethanol;5-(Hydroxymethyl)-2-Phenoxypyridine 97%;5-(Hydroxymethyl)-2-Phenoxypyridine97%;5-(Hydroxymethyl)-2-Phenoxypyridine | C12H11NO2 |
| 101990-69-6 | 2,6-Dichloro-4-Pyridinyl Methanol;2,6-Dichloro-4-(Hydroxymethyl)Pyridine;2,6-Dichloropyridine-4-Methanol ,98%;(2,6-Dichloropyridin- 4-Yl)Methanol | C6H5Cl2NO |
| 101990-70-9 | 5-(Chloromethyl)-2-methoxypyridine | C7H8ClNO |
| 101990-72-1 | 2,6-Dichloro-4-(Chloromethyl)Pyridine;4-(Chloromethyl)-2,6-dichloropyridine;4-Chloromethyl-2,6-dichloropyridine;MFCD03783562 | C6H4Cl3N |
| 101990-73-2 | 2-Chloro-4-(chloromethyl)pyridine | C6H5Cl2N |
| 101993-01-5 | Tetrahydrothien-3-ylamine | C4H9NS |
| 102000-72-6 | 3-Vinyl-2-Pyridinamine;2-Pyridinamine,3-ethenyl-;3-vinylpyridin-2-amine | C7H8N2 |
| 102000-73-7 | 3-Bromo-4-Nitrobenzonitrile | C7H3BrN2O2 |
| 102001-19-4 | (3,4-Dimethylphenyl)(2-Pyridinyl)Methanone;2-(3,4-Dimethylbenzoyl)pyridine | C14H13NO |
| 102013-72-9 | 3,6,9,12,15,18,21,24,27-Nonaoxaoctacosanoic acid | C19H38O11 |
| 102016-58-0 | 4-(Methylthio)cinnamic acid;3-[4-(Methylsulfanyl)phenyl]acrylic acid | C10H10O2S |
| 102029-44-7 | (R)-4-Benzyl-2-oxazolidinone;(4R)-4-benzyl-1,3-oxazolidin-2-one | C10H11NO2 |
| 102029-60-7 | AMPSO sodium salt;3-((1,1-Dimethyl-2-hydroxyethyl)amino)-2-hydroxypropanesulfonic acid sodium salt | C7H16NNaO5S |
| 102029-73-2 | Acetyl coenzyme A sodium salt | C23H37N7NaO17P3S |
| 102029-74-3 | L-Tyrosyl-L-Prolyl-L-Phenylalanyl-L-Valyl-L-alpha-Glutamyl-L-Prolyl-L-Isoleucine;TYR-PRO-PHE-VAL-GLU-PRO-ILE OH;BETA-CASOMORPHIN (1-7), HUMAN;TYR-PRO-PHE-VAL-GLU-PRO-ILE | C44H61N7O11 |
| 102029-77-6 | (4aR,6R,7R,7aS)-6-(6-Amino-9H-Purin-9-Yl)Tetrahydro-4H-Furo[3,2-d][1,3,2]Dioxaphosphinine-2,7-Diol 2-Oxide - 2-Amino-2-(Hydroxymethyl)-1,3-Propanediol (1:1);(4aR,6R,7<wbr>R,7aS) 2-<wbr>Oxyde de <wbr>6-(6-amin<wbr>o-9H-puri<wbr>n-9-yl)té<wbr>trahydro-<wbr>4H-furo[3<wbr>,2-d][1,3<wbr>,2]dioxap<wbr>hosphinin<wbr>e-2,7-dio<wbr>l - 2-ami<wbr>no-2-(hyd<wbr>roxyméthy<wbr>l)-1,3-pr<wbr>opanediol<wbr> (1:1);(4aR,6R,7<wbr>R,7aS)-6-<wbr>(6-Amino-<wbr>9H-purin-<wbr>9-yl)tetr<wbr>ahydro-4H<wbr>-furo[3,2<wbr>-d][1,3,2<wbr>]dioxapho<wbr>sphinin-2<wbr>,7-diol-2<wbr>-oxid --2<wbr>-amino-2-<wbr>(hydroxym<wbr>ethyl)-1,<wbr>3-propand<wbr>iol (1:1);(4aR,6R,7<wbr>R,7aS)-6-<wbr>(6-Amino-<wbr>9H-purin-<wbr>9-yl)tetr<wbr>ahydro-4H<wbr>-furo[3,2<wbr>-d][1,3,2<wbr>]dioxapho<wbr>sphinine-<wbr>2,7-diol <wbr>2-oxide -<wbr> 2-amino-<wbr>2-(hydrox<wbr>ymethyl)-<wbr>1,3-propa<wbr>nediol (1<wbr>:1) | C14H23N6O9P |
| 102029-80-1 | (2S)-2-Amino-Propanamide Hydrobromide (1:1);L-ALANINE AMIDE HYDROBROMIDE;L-Alaninamide Hydrobromide;ALANINE-NH2 HBR | C3H9BrN2O |
| 102029-81-2 | Alanine-1-13C;Alanine-1-13C;Ccris 6559;282421_Aldrich | C3H7NO2 |
| 102029-87-8 | Adenosine 5'-(trihydrogen diphosphate) cyclohexanamine salt | C10H15N5O10P2.2(C6H13N) |
| 102029-89-0 | H-Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH;Sar-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-OH;H-Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH;[Sar1]Angiotensin II【Guinea Pig】 | C49H71N13O10 |
| 102029-92-5 | L-Arginyl-L-phenylalanine diacetate | C15H23N5O3.2(C2H4O2) |
| 102029-95-8 | 5'-Adenylic Acid Monoanhydride With Sulfuric Acid Disodium Salt;ADENOSINE-5'-O-PHOSPHOSULFATE SODIUM SALT;ADENOSINE 5'-PHOSPHOSULFATE SODIUM SALT;ADENOSINE 5'-PHOSPHOSULFATE SODIUM | C10H13N5NaO10PS |
| 102029-99-2 | N-(Phenylmethyl)-L-histidine methyl ester dihydrochloride | C14H17N3O2.2(HCl) |
| 102036-29-3 | Protosappanin B;(-)-Protosappanin B; (7S,12aS)-7,8-Dihydro-7-(hydroxymethyl)-6H-dibenz[b,d]oxocin-3,7,10,11-tetrol | C16H16O6 |
| 102040-03-9 | Tubeimoside A | C63H98O29 |
| 102042-09-1 | 21-Hydroxyoligomycin A;(4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22S,28S)-22-Ethyl-7,11,14,15,23-Pentahydroxy-6'-[(2R)-2-Hydroxypropyl]-5',6,8,10,12,14,15,16,28-Nonamethyl-Spiro[2,26-Dioxabicyclo[23.3.1]Nonacosa-4,18,20-Triene-27,2'-Tetrahydropyran]-3,9,13-Trione;(4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22S,28S)-22-Ethyl-7,11,14,15,23-Pentahydroxy-6'-[(2R)-2-Hydroxypropyl]-5',6,8,10,12,14,15,16,28-Nonamethylspiro[2,26-Dioxabicyclo[23.3.1]Nonacosa-4,18,20-Triene-27,2'-Tetrahydropyran]-3,9,13-Trione;(4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22S,28S)-22-Ethyl-7,11,14,15,23-Pentahydroxy-6'-[(2R)-2-Hydroxypropyl]-5',6,8,10,12,14,15,16,28-Nonamethyl-Spiro[2,26-Dioxabicyclo[23.3.1]Nonacosa-4,18,20-Triene-27,2'-Oxane]-3,9,13-Trione | C45H74O12 |
| 102044-69-9 | Ceftizoxime Impurity 30 (Double Bond 2-Isomer);(2R,6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid | C13H13N5O5S2 |
| 102045-96-5 | (S)-2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid;(S)-2,2-Dimethyldioxolane-4-carboxylic acid; (S)-2,3-(Isopropylidenedioxy)propionic acid | C6H10O4 |
| 102047-33-6 | N-[(Benzyloxy)Carbonyl]-L-Alanyl-6-Imino-L-Lysyl-6-Imino-N-(4-Methoxy-2-Naphthyl)-L-Lysinamide Acetate (1:1);Acide acé<wbr>tique - N<wbr>-[(benzyl<wbr>oxy)carbo<wbr>nyl]-L-al<wbr>anyl-6-im<wbr>ino-L-lys<wbr>yl-6-imin<wbr>o-N-(4-mé<wbr>thoxy-2-n<wbr>aphtyl)-L<wbr>-lysinami<wbr>de (1:1);L-Lysinam<wbr>ide, N-[(<wbr>phenylmet<wbr>hoxy)carb<wbr>onyl]-L-a<wbr>lanyl-6-i<wbr>mino-L-ly<wbr>syl-6-imi<wbr>no-N-(4-m<wbr>ethoxy-2-<wbr>naphthale<wbr>nyl)-, ac<wbr>etate (1:<wbr>1);N-[(Benzy<wbr>loxy)carb<wbr>onyl]-L-a<wbr>lanyl-6-i<wbr>mino-L-ly<wbr>syl-6-imi<wbr>no-N-(4-m<wbr>ethoxy-2-<wbr>naphthyl)<wbr>-L-lysina<wbr>midacetat<wbr> (1:1) | C36H48N8O8 |
| 102052-95-9 | 3-Deazaneplanocin;(1S,2R,5R)-5-(4-Amino-1H-imidazo[4,5-c]pyridin-1-yl)-3-(hydroxymethyl)-3-cyclopentene-1,2-diol; NSC 617989 | C12H14N4O3 |
| 102056-97-3 | N-Tritylhomoserine - N,N-Diethylethanamine (1:1);N-TRITYL-L-HOMOSERINETRIETHYLAMINESALT | C29H38N2O3 |
| 102062-46-4 | 3-[(4'-Amino-3,3',5,5'-tetramethyl[1,1'-biphenyl]-4-yl)amino]-1-propanesulfonic acid monosodium salt | C19H25N2O3SNa |
| 102065-86-1 | Azetidin-3-amine dihydrochloride | C3H8N2.2(HCl) |
| 102065-89-4 | 3-Azetidinamine dihydrochloride | C3H8N2.2(HCl) |
| 102065-92-9 | 3-Acetamidoazetidine hydrochloride | C5H10N2O.HCl |
| 102068-15-5 | PGLa;741: PN: US20050058603 SEQID: 736 claimed protein; MSI 499; PGLa; PGLa ion channel-forming peptide | C88H162N26O22S |
| 102072-84-4 | 5-Phthalazinamine;MFCD08272072;phthalazine-5-ylamine;Quinazolin-8-amine | C8H7N3 |
| 102074-19-1 | 5-Methyl-3-pyridinemethanol;3-Hydroxymethyl-5-methylpyridine; (5-Methylpyridin-3-yl)methanol | C7H9NO |
| 102082-89-3 | 2,6-Difluorocinnamic acid;trans-2,6-Difluorocinnamicacid; (2E)-3-(2,6-Difluorophenyl)acrylic acid | C9H6F2O2 |
| 102088-01-7 | 1,2,3-(1,3-<Sup>13</Sup>C<Sub>2</Sub>)Propanetriol;[1,3-13C2]glycerol;Glycerol-1,3-13C2;492639_ALDRICH | C13C2H8O3 |
| 102088-39-1 | 37,38,39,40,41,42-Hexahydroxy-Heptacyclo[31.3.1.13,7.19,13.115,19.121,25.127,31]Dotetraconta-1(37),3,5,7(42),9,11,13(41),15,17,19(40),21,23,25(39),27,29,31(38),33,35-Octadecaene-5,11,17,23,29,35-Hexasulfonic Acid;Hexahydroxycalix[6]Arenehexasulfonic Acid Hexasulfo(Hexahydroxy)Calix[6]Arene;4-SULFOCALIX[6]ARENE (CONTAINS CA.15% WATER);HEXAHYDROXYCALIX[6]ARENEHEXASULFONIC ACID | C42H36O24S6 |
| 102089-74-7 | Boc-D-Phenylglycinol;(R)-N-(tert-Butoxycarbonyl)-2-phenylglycinol | C13H19NO3 |
| 102092-51-3 | (3-Bromophenyl)(4-Methylphenyl)Methanone;(3-Bromophenyl)(p-tolyl)methanone;3-Bromo-4'-methylbenzophenone;MFCD06201458 | C14H11BrO |
| 102096-60-6 | (3R)-4,4-Dimethyl-2-Oxotetrahydro-3-Furanyl Acetate;O-Acetylpantolactone | C8H12O4 |
| 102096-80-0 | Hydrazine-d<sub>4</sub> mono(hydrate-d<sub>2</sub>) | N2D4.D2O |
| 102110-73-6 | Albumins, Blood Serum, Azo |